Latest news
Tabcorp Sees EPS Earnings Accretion From Year Two - MoomooMoomoo · Sun, 09 Aug 2026 23:23:34 GMTUndervalued REIT delivers strong earnings growth - Morningstar AustraliaMorningstar Australia · Fri, 07 Aug 2026 01:06:56 GMTBioMarin Pharmaceutical Q2 Earnings Call Highlights - TradingViewTradingView · Thu, 06 Aug 2026 23:03:49 GMTMergers as Strategic Architecture: Rethinking How to Evaluate the AstraZeneca–BMS Rumors - Pharmaceutical ExecutivePharmaceutical Executive · Thu, 06 Aug 2026 10:02:44 GMTEQH Q2 Deep Dive: Merger Momentum, Organic Growth, and Strategic Divestiture - StockStoryStockStory · Thu, 06 Aug 2026 09:10:43 GMTEquitable Holdings Reports Q2 Results and Corebridge Merger - The Globe and MailThe Globe and Mail · Wed, 05 Aug 2026 21:22:00 GMTAccretion Nutraveda FY26 Results: Revenue Jumps 110%, PAT Surges 103% - scanx.tradescanx.trade · Tue, 04 Aug 2026 19:22:45 GMTIntegration Risks Threaten Alcoa’s Transaction Synergies, Earnings Accretion, and Balance Sheet Strength - The Globe and MailThe Globe and Mail · Sun, 02 Aug 2026 06:10:00 GMT